[ET Net News Agency, 19 February 2024] BIOCYTOGEN-B (02315) fell 17% to HK$7.2, dipping
below the 10-D SMA of HK$8.381.
It hits an intra-day low of HK$7.1, hitting a historical low, and an intra-day high of
HK$8.67. The total shares traded was 91,000, with a value of HK$707,635. The active
buy/sell ratio is 72:28, with net buying turnover of HK$306,085. J.P. MORGAN BRO (HK)
accounts for greatest net responsive buying turnover of HK$54,682, with volume weighted
average price of HK$7.915. CITIGROUP GLOBAL accounts for greatest net responsive selling
turnover of HK$167,455, with volume weighted average price of HK$7.789.
Basic Information
=================
----------------------------------
Nominal 7.200 % Chg -16.96%
High 8.670 Low 7.100
Shares Tr 91,000 Turnover 707,635
10-D SMA 8.381 %H.V 100.173
20-D SMA 9.010 VWAP 7.776
50-D SMA 10.215 RSI14 35.384
----------------------------------
Status: Dipping below the 10-D SMA, hitting a historical low, active buy/sell ratio is
72:28, with net buying turnover of HK$306,085
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
BIOCYTOGEN-B (02315) 7.20 -16.96
GENSCRIPT BIO (01548) 13.54 -3.15
INNOVENT BIO (01801) 37.95 -5.36
EVEREST MED-B (01952) 16.94 -2.08
WUXI BIO (02269) 16.52 -4.40
BEIGENE (06160) 89.10 -1.55
SCICLONE PHARMA (06600) 12.38 +3.17
ZAI LAB (09688) 15.48 -4.21
AKESO (09926) 43.45 -1.02
REMEGEN (09995) 19.48 +0.21
-----------------------------------------------
(ed)